Tefron Ltd.
TFRFF
$6.43
-$0.03-0.46%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -13.63% | -13.59% | -28.57% | -12.29% | -21.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -13.63% | -13.59% | -28.57% | -12.29% | -21.86% |
| Cost of Revenue | -11.70% | -12.84% | -23.53% | -11.73% | -19.83% |
| Gross Profit | -20.61% | -16.47% | -44.46% | -14.30% | -28.38% |
| SG&A Expenses | 13.74% | -7.48% | -10.17% | -6.30% | -8.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -37.87% | -- | -- | -- |
| Total Operating Expenses | -7.20% | -11.65% | -20.98% | -10.71% | -18.15% |
| Operating Income | -125.35% | -68.51% | -106.14% | -29.06% | -56.26% |
| Income Before Tax | -171.06% | -93.79% | -127.82% | -30.30% | -59.42% |
| Income Tax Expenses | -189.80% | 1,206.67% | -76.11% | -51.19% | -65.13% |
| Earnings from Continuing Operations | -164.42% | -134.43% | -143.48% | -24.84% | -56.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -164.42% | -134.43% | -143.48% | -24.84% | -56.92% |
| EBIT | -125.35% | -68.51% | -106.14% | -29.06% | -56.26% |
| EBITDA | -71.02% | -44.08% | -84.88% | -26.27% | -44.63% |
| EPS Basic | -160.00% | -136.09% | -142.86% | -22.86% | -57.14% |
| Normalized Basic EPS | -166.14% | -93.49% | -127.44% | -28.45% | -59.62% |
| EPS Diluted | -164.29% | -137.43% | -146.88% | -21.21% | -57.58% |
| Normalized Diluted EPS | -170.89% | -93.40% | -130.02% | -26.91% | -60.03% |
| Average Basic Shares Outstanding | 7.37% | -4.59% | 1.45% | -2.58% | 0.52% |
| Average Diluted Shares Outstanding | 0.21% | -5.86% | -7.25% | -4.61% | 1.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | 0.37% | -- |